SEMA3C and prostate carcinoma: Sema3C is an indicator of poor prognosis and progression of glioblastoma, prostate cancer, breast cancer, liver cancer, gastric cancer, pancreatic cancer, and lung cancer [11,41,42,43,44,45,46,47,48].